# Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients

> **NCT04023760** · PHASE4 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 14 (actual)

## Conditions studied

- Pharmacokinetics
- Kidney Transplant
- Lung Transplant

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT04023760
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-26
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-03-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04023760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04023760, "Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04023760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*